TIMOTHY E. MORRIS - 21 Jun 2023 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role
Director
Signature
/s/ Lori Braender, as Attorney-In-Fact
Issuer symbol
AQST
Transactions as of
21 Jun 2023
Net transactions value
$0
Form type
4
Filing time
23 Jun 2023, 12:27:43 UTC
Previous filing
17 Aug 2022
Next filing
28 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AQST Stock Option (right to purchase) Award $0 +25,000 $0.000000 25,000 21 Jun 2023 Common Stock 25,000 $2.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the options vest as follows: 100% of the underlying shares vest June 21, 2024, subject to Mr. Morris' continuous service with the Issuer from the grant date through the applicable vesting date.